BGDO | Belgian Group of Digestive Oncology

  • Plein écran
  • Ecran large
  • Ecran étroit
  • Increase font size
  • Default font size
  • Decrease font size

Planned

SUNLAND

E-mail Print PDF

A RANDOMIZED PHASE II DOUBLE-BLIND TRIAL OF SUNITINIB VERSUS PLACEBO IN COMBINATION WITH LANREOTIDE IN PATIENTS WITH PROGRESSIVE ADVANCED/METASTATIC MIDGUT CARCINOID TUMORS

Eudract Number: 2012-001098-94

Start inclusion: Q1 2014

End of inclusion: Q1 2016

Last Updated on Monday, 23 December 2013 20:25

QOLINPAC

E-mail Print PDF

Randomized crossover trial to assess the effects and quality of life in patients with locally advanced or metastatic pancreatic cancer treated with gemcitabine in combination with nab-paclitaxel: QOLINPAC


Eudract number 2013-004101-75


Submission planned: Q1 2014


Start inclusion: Q1 204


End of inclusion: Q1 2015

Last Updated on Monday, 23 December 2013 20:30
You are here: Clinical trial - registries Planned studies